Physician profile
Paul Kamin
NPI 1194773143
$3,088.70
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,789 · 2020: $34.37 · 2021: $102 · 2022: $163.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,130.68 | 2019-2021 | |
| Boston Scientific Corporation | $296.58 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $147.24 | 2019-2021 | |
| Cook Medical LLC | $119.70 | 2019 | |
| Angiodynamics, INC. | $105.13 | 2019 | |
| Inari Medical, INC. | $81.31 | 2022 | |
| W. L. Gore & Associates, INC. | $37.43 | 2019-2022 | |
| Medtronic Vascular, INC. | $29.86 | 2019 | |
| Terumo Medical Corporation | $24.26 | 2019 | |
| Shockwave Medical, INC | $22.91 | 2021 | |
| Abbott Laboratories | $19.75 | 2021 | |
| Ge Healthcare | $18.27 | 2022 | |
| Cardiovascular Systems INC. | $15.84 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.09 | 2022 | |
| Siemens Medical Solutions USA, INC. | $13.53 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $11.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kamin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.